G

Genpharmasec Ltd
BSE:531592

Watchlist Manager
Genpharmasec Ltd
BSE:531592
Watchlist
Price: 2.79 INR -3.13% Market Closed
Market Cap: 1.5B INR
Have any thoughts about
Genpharmasec Ltd?
Write Note

Genpharmasec Ltd
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Genpharmasec Ltd
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
G
Genpharmasec Ltd
BSE:531592
Revenue
â‚ą296.4m
CAGR 3-Years
0%
CAGR 5-Years
96%
CAGR 10-Years
N/A
S
Shree Global Tradefin Ltd
BSE:512463
Revenue
â‚ą9.6B
CAGR 3-Years
960%
CAGR 5-Years
131%
CAGR 10-Years
N/A
MSTC Ltd
NSE:MSTCLTD
Revenue
â‚ą7.6B
CAGR 3-Years
-7%
CAGR 5-Years
-25%
CAGR 10-Years
N/A
Adani Enterprises Ltd
NSE:ADANIENT
Revenue
â‚ą965.5B
CAGR 3-Years
24%
CAGR 5-Years
18%
CAGR 10-Years
5%
Refex Industries Ltd
NSE:REFEX
Revenue
â‚ą13.8B
CAGR 3-Years
30%
CAGR 5-Years
25%
CAGR 10-Years
N/A
Indiamart Intermesh Ltd
NSE:INDIAMART
Revenue
â‚ą13B
CAGR 3-Years
22%
CAGR 5-Years
18%
CAGR 10-Years
N/A
No Stocks Found

Genpharmasec Ltd
Glance View

Market Cap
1.5B INR
Industry
Trading Companies & Distributors

Genpharmasec Ltd. engages in manufacturing and trading in Organic and Inorganic Chemicals, Dyes and Pigments Its products include potassium hydroxide and caustic soda. The company is headquartered in Mumbai, Maharashtra. The firm is engaged in the business of diagnostic equipment, pharmaceutical, medicinal, and medicated preparations, patent medicines, drugs, herbs, and in pharmaceutical, medicinal, and proprietary and industrial preparations, compounds and articles of kinds, chemists, druggists, and chemical manufacturers.

GENPHARMA Intrinsic Value
0.92 INR
Overvaluation 67%
Intrinsic Value
Price
G

See Also

What is Genpharmasec Ltd's Revenue?
Revenue
296.4m INR

Based on the financial report for Jun 30, 2024, Genpharmasec Ltd's Revenue amounts to 296.4m INR.

What is Genpharmasec Ltd's Revenue growth rate?
Revenue CAGR 5Y
96%

Over the last year, the Revenue growth was 20%.

Back to Top